REFERENCES
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011; Mar–Apr;61(2):69–90.
- Hammond EC, Seidman H: Smoking and cancer in the United States. Prev Med. 1980;9:169–173.
- Mountain CF: Revisions in the international system for staging lung cancer. Chest. 1997;111:1710.
- Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, Dong Q, Zhang Q, Gu X, Vijayakrishnan J: Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25. 1. Nat Genet. 2008;40:616.
- Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P: A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature. 2008;452:633–637.
- McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J: Lung cancer susceptibility locus at 5p15. 33. Nat Genet. 2008;40:1404–1406.
- Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, Manolescu A, Thorleifsson G, Stefansson H, Ingason A: A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 2008;452: 638–642.
- Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, Matakidou A, Qureshi M, Dong Q, Gu X, Chen WV: Common 5p15. 33 and 6p21. 33 variants influence lung cancer risk. Nat Gen. 2008;40:1407.
- Broderick P, Wang Y, Vijayakrishnan J, Matakidou A, Spitz MR, Eisen T, Amos CI, Houlston RS: Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res. 2009;69:6633.
- Hsiung CA, Lan Q, Hong YC, Chen CJ, Hosgood HD III, Chang IS, Chatterjee N, Brennan P, Wu C, Zheng W: The 5p15. 33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet. 2010;6:e1001051.
- Miki D, Kubo M, Takahashi A, Yoon KA, Kim J, Lee GK, Zo JI, Lee JS, Hosono N, Morizono T: Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nat Genet. 2010;42:893–896.
- Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, Mirabello L, Jacobs K, Wheeler W, Yeager M: A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet. 2009;85:679–691.
- Hu Z, Wu C, Shi Y, Guo H, Zhao X, Yin Z, Yang L, Dai J, Hu L, Tan W: A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet. 2011;43:792–796.
- Barrett JC, Haploview: visualization and analysis of SNP genotype data. (Adapted from Genetic Variation (Weiner et al. eds.), CSHL Press). Cold Spring Harbor Protocols 2009: pdb. ip71.
- Nyholt DR: A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet. 2004;74:765–769.
- Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, He L, Shi Y: A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis. bio-x. cn). Cell Res. 2009;19:519–523.
- Yong Y, Lin H: SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15:97–98.
- Cairns P: Gene methylation and early detection of genitourinary cancer: the road ahead. Nat Rev Cancer. 2007;7:531–543.
- Van Dyke AL, Cote ML, Wenzlaff AS, Abrams J, Land S, Iyer P, Schwartz AG: Chromosome 5p region SNPs are associated with risk of NSCLC among women. J Cancer Epidemiol. 2009;2009:242151. doi:10.1155/2009/242151.
- Hsu CP, Miaw J, Hsia JY, Shai SE, Chen CY: Concordant expression of the telomerase-associated genes in non-small cell lung cancer. Eur J Surg Oncol. 2003;29:594–599.
- Brennan P, Hainaut P, Boffetta P: Genetics of lung-cancer susceptibility. Lancet Oncol. 2011;12:399–408.
- Wu TC, Lin P, Hsu CP, Huang YJ, Chen CY, Chung WC, Lee H, Ko JL: Loss of telomerase activity may be a potential favorable prognostic marker in lung carcinomas. Lung Cancer. 2003;41:163–169.
- Counter CM, Meyerson M, Eaton EN, Ellisen LW, Caddle SD, Haber DA, Weinberg RA: Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene. 1998;16:1217.
- Agarwal S, Loh YH, McLoughlin EM, Huang J, Park IH, Miller JD, Huo H, Okuka M, Dos Reis RM, Loewer S: Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature. 2010;464:292–296.
- Maida Y, Yasukawa M, Furuuchi M, Lassmann T, Possemato R, Okamoto N, Kasim V, Hayashizaki Y, Hahn WC, Masutomi K: An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature. 2009;461:230–235.